2026-526237-26-00招募中1 期
A Trial to Evaluate the Safety and Drug Levels of Single and Multiple Oral Doses of AT-587 in Healthy Adults
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 62
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Atea Clinical Trial Information
Scientific
Atea Pharmaceuticals Inc.
研究点 (1)
Loading locations...
相似试验
招募中
2 期
A trial to determine the safety and tolerability of transplanted stem cellderived dopamine neurons to the brains of individuals with Parkinson's Disease.Parkinson's disease2024-511237-35-00Region Skane4
招募中
1 期
A trial to investigate the safety and pharmacokinetics of GRT6019 in healthy male participants.2025-523587-20-00Gruenenthal GmbH24
招募中
1 期
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants with Advanced Solid Malignancies2024-511453-22-00Kumquat Biosciences Inc.112
招募中
2 期
A study to evaluate the safety and efficacy of the tumor-targeting human antibody-cytokine fusion protein L19TNF plus lomustine in patients with glioblastoma at first progressionGlioblastoma2022-501822-39-00Philogen S.p.A.113
招募中
1 期
A phase 1b trial to study the safety and effect of ZP9830 in patients with plaque psoriasisPlaque Psoriasis2026-525220-15-00Zealand Pharma A/S32